NYSE:BDX - Becton Dickinson and Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$248.34 +3.83 (+1.57 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$244.51
Today's Range$245.00 - $248.39
52-Week Range$208.62 - $265.87
Volume1.48 million shs
Average Volume1.15 million shs
Market Capitalization$66.82 billion
P/E Ratio22.56
Dividend Yield1.26%
Beta1.23
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits, reagent systems, bench-side solutions, and molecular indexing and next-generation sequencing sample preparation products, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, thoracic and abdominal drainage, and surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.98 billion
Cash Flow$18.4777 per share
Book Value$79.54 per share

Profitability

Net Income$311 million

Miscellaneous

Employees76,032
Market Cap$66.82 billion
OptionableOptionable

Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and declared a quarterly dividend on Wednesday, January 23rd. Shareholders of record on Friday, March 8th will be paid a dividend of $0.77 per share on Friday, March 29th. This represents a $3.08 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date of this dividend is Thursday, March 7th. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) issued its earnings results on Tuesday, February, 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.58 by $0.12. The medical instruments supplier had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.10 billion. Becton Dickinson and had a net margin of 5.69% and a return on equity of 14.65%. Becton Dickinson and's quarterly revenue was up 35.1% on a year-over-year basis. During the same period last year, the business earned $2.48 EPS. View Becton Dickinson and's Earnings History.

When is Becton Dickinson and's next earnings date?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Becton Dickinson and.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and issued an update on its FY 2019 earnings guidance on Tuesday, February, 5th. The company provided earnings per share guidance of $12.05-12.15 for the period, compared to the Thomson Reuters consensus estimate of $12.12. The company issued revenue guidance of $17.342-17.501 billion, compared to the consensus revenue estimate of $17.43 billion.

What price target have analysts set for BDX?

11 brokerages have issued twelve-month price targets for Becton Dickinson and's stock. Their predictions range from $175.00 to $280.00. On average, they anticipate Becton Dickinson and's stock price to reach $254.0909 in the next year. This suggests a possible upside of 2.3% from the stock's current price. View Analyst Price Targets for Becton Dickinson and.

What is the consensus analysts' recommendation for Becton Dickinson and?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Becton Dickinson and.

Has Becton Dickinson and been receiving favorable news coverage?

News headlines about BDX stock have trended somewhat positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Becton Dickinson and earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term.

Who are some of Becton Dickinson and's key competitors?

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 66)
  • Mr. Thomas E. Polen Jr., Pres & COO (Age 46)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 62)
  • Mr. Samrat S. Khichi, Exec. VP & Gen. Counsel (Age 52)
  • Mr. Patrick K. Kaltenbach, Exec. VP & Pres of the Life Sciences Segment (Age 56)

Who are Becton Dickinson and's major shareholders?

Becton Dickinson and's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.20%), Oregon Public Employees Retirement Fund (2.45%), Fundsmith LLP (1.39%), Geode Capital Management LLC (1.19%), Northern Trust Corp (1.19%) and Fiera Capital Corp (1.05%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Charles R Bodner, David F Melcher, Ellen R Strahlman, Gary M Cohen, James C Lim, James W Borzi, Jeffrey S Sherman, John E Gallagher, Linda M Tharby, Nabil Shabshab, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Which major investors are selling Becton Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including 1832 Asset Management L.P., Fiera Capital Corp, New York State Common Retirement Fund, Montag & Caldwell LLC, Bessemer Group Inc., Jarislowsky Fraser Ltd, Bank of New York Mellon Corp and Standard Life Aberdeen plc. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Charles R Bodner, James C Lim, James W Borzi, John E Gallagher, Nabil Shabshab, Ribo Alberto Mas, Thomas E Polen Jr, Timothy M Ring and Vincent A Forlenza. View Insider Buying and Selling for Becton Dickinson and.

Which major investors are buying Becton Dickinson and stock?

BDX stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Mackenzie Financial Corp, BlackRock Inc., Findlay Park Partners LLP, Geode Capital Management LLC, Amundi Pioneer Asset Management Inc., CI Investments Inc. and Investec Asset Management LTD. View Insider Buying and Selling for Becton Dickinson and.

How do I buy shares of Becton Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $248.34.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $66.82 billion and generates $15.98 billion in revenue each year. The medical instruments supplier earns $311 million in net income (profit) each year or $11.01 on an earnings per share basis. Becton Dickinson and employs 76,032 workers across the globe.

What is Becton Dickinson and's official website?

The official website for Becton Dickinson and is http://www.bd.com.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


MarketBeat Community Rating for Becton Dickinson and (NYSE BDX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  432 (Vote Outperform)
Underperform Votes:  510 (Vote Underperform)
Total Votes:  942
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/15/2019 by MarketBeat.com Staff

Featured Article: What is intrinsic value?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel